» Articles » PMID: 27725860

MicroRNA-561 Inhibits Gastric Cancercell Proliferation and Invasion by Downregulating C-Myc Expression

Overview
Journal Am J Transl Res
Specialty General Medicine
Date 2016 Oct 12
PMID 27725860
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Gastric cancer (GC) causes nearly one million deaths worldwide each year. However, the molecular pathway of GC development remains unclear. Increasing evidences have shown that microRNAs (miRNAs) are highly associated with tumor development. However, relative little is known about the potential role of miRNAs in gastric cancer development. In the present study, we showed that miR-561 was down-regulated frequently in human GCs cell lines and tissues, and its expression was associated with tumor-node-metastasis (pTNM) stage. Enforced expression of miR-561 in GC cells inhibited cell proliferation and invasion in vitro. In contrast, knockdown of miR-561 had the opposite effect on cell proliferation and invasion. Moreover, c-Myc was identified as a potential miR-561 target. Further studies confirmed that miR-561 suppressed the expression of c-Myc by directly binding to its 3'-untranslated region. Restoration of c-Myc in miR-561-overexpressed GC cells reversed the suppressive effects of miR-561 and c-Myc was inversely correlated with miR-561 expression in GC tissues. These results demonstrate that miR-561 acts as a novel tumor suppressor in GC by targeting c-Myc gene and inhibiting GC cells proliferation and invasion. These findings contribute to current understanding of the functions of miR-561 in GC.

Citing Articles

MicroRNA-561-3p indirectly regulates the PD-L1 expression by targeting ZEB1, HIF1A, and MYC genes in breast cancer.

Yousefi A, Sotoodehnejadnematalahi F, Nafissi N, Zeinali S, Azizi M Sci Rep. 2024; 14(1):5845.

PMID: 38462658 PMC: 10925600. DOI: 10.1038/s41598-024-56511-6.


MicroRNA signatures differentiate types, grades, and stages of breast invasive ductal carcinoma (IDC): miRNA-target interacting signaling pathways.

Verma V, Beevi S, Nair R, Kumar A, Kiran R, Alexander L Cell Commun Signal. 2024; 22(1):100.

PMID: 38326829 PMC: 10851529. DOI: 10.1186/s12964-023-01452-2.


Retraction: MicroRNA-33b Suppresses Migration and Invasion by Targeting c-Myc in Osteosarcoma Cells.

PLoS One. 2022; 17(6):e0269899.

PMID: 35675351 PMC: 9176801. DOI: 10.1371/journal.pone.0269899.


Retraction: MicroRNA-153 Inhibits Osteosarcoma Cells Proliferation and Invasion by Targeting TGF-β2.

PLoS One. 2022; 17(6):e0269902.

PMID: 35675303 PMC: 9176757. DOI: 10.1371/journal.pone.0269902.


Retraction: MicroRNA-137 Upregulation Increases Bladder Cancer Cell Proliferation and Invasion by Targeting PAQR3.

PLoS One. 2022; 17(6):e0269903.

PMID: 35675299 PMC: 9176799. DOI: 10.1371/journal.pone.0269903.


References
1.
Ikeda S, Sumii H, Akiyama K, Watanabe S, Ito S, Inoue H . Amplification of both c-myc and c-raf-1 oncogenes in a human osteosarcoma. Jpn J Cancer Res. 1989; 80(1):6-9. PMC: 5917676. DOI: 10.1111/j.1349-7006.1989.tb02236.x. View

2.
Yang L . Incidence and mortality of gastric cancer in China. World J Gastroenterol. 2006; 12(1):17-20. PMC: 4077485. DOI: 10.3748/wjg.v12.i1.17. View

3.
Zhou F, Zhu H, Luo D, Wang M, Dong X, Hong Y . A functional polymorphism in Pre-miR-146a is associated with susceptibility to gastric cancer in a Chinese population. DNA Cell Biol. 2012; 31(7):1290-5. DOI: 10.1089/dna.2011.1596. View

4.
Yang Q, Jie Z, Cao H, Greenlee A, Yang C, Zou F . Low-level expression of let-7a in gastric cancer and its involvement in tumorigenesis by targeting RAB40C. Carcinogenesis. 2011; 32(5):713-22. DOI: 10.1093/carcin/bgr035. View

5.
Khanna A, Bockelman C, Hemmes A, Junttila M, Wiksten J, Lundin M . MYC-dependent regulation and prognostic role of CIP2A in gastric cancer. J Natl Cancer Inst. 2009; 101(11):793-805. DOI: 10.1093/jnci/djp103. View